Gary P. Hingorani

1.3k total citations
17 papers, 433 citations indexed

About

Gary P. Hingorani is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Gary P. Hingorani has authored 17 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Physiology and 4 papers in Immunology. Recurrent topics in Gary P. Hingorani's work include Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Asthma and respiratory diseases (4 papers). Gary P. Hingorani is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Asthma and respiratory diseases (4 papers). Gary P. Hingorani collaborates with scholars based in United States. Gary P. Hingorani's co-authors include Stephen T. Rapundalo, Annette M. Doherty, Jennifer Otten, Robert L. Panek, Terry C. Major, Maryrose J. Conklyn, Henry J. Showell, Dylan P. Hartley, Ronald B. Franklin and Kevin M. Koch and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Gary P. Hingorani

17 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary P. Hingorani United States	11	196	163	82	59	56	17	433
Rita Nigam Canada	8	155 0.8×	111 0.7×	76 0.9×	18 0.3×	45 0.8×	17	359
Floyd A. Green United States	14	137 0.7×	170 1.0×	35 0.4×	32 0.5×	23 0.4×	34	437
Mohan V. Chari United States	12	41 0.2×	139 0.9×	36 0.4×	63 1.1×	126 2.3×	19	476
Joanna Budworth United Kingdom	8	71 0.4×	239 1.5×	27 0.3×	26 0.4×	115 2.1×	8	383
Roger Meurer United States	13	304 1.6×	277 1.7×	172 2.1×	10 0.2×	100 1.8×	20	700
Britta Lundquist Sweden	10	89 0.5×	220 1.3×	80 1.0×	21 0.4×	31 0.6×	20	357
Stephen R. Turner United States	5	53 0.3×	111 0.7×	60 0.7×	12 0.2×	25 0.4×	11	381
G. Müller Germany	10	91 0.5×	176 1.1×	219 2.7×	12 0.2×	35 0.6×	25	592
Martha Lucía Serrano Colombia	10	69 0.4×	278 1.7×	58 0.7×	28 0.5×	75 1.3×	47	546
Nahed K. Ahmed United States	13	56 0.3×	272 1.7×	67 0.8×	16 0.3×	87 1.6×	30	533

Countries citing papers authored by Gary P. Hingorani

Since Specialization

Citations

This map shows the geographic impact of Gary P. Hingorani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary P. Hingorani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary P. Hingorani more than expected).

Fields of papers citing papers by Gary P. Hingorani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary P. Hingorani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary P. Hingorani. The network helps show where Gary P. Hingorani may publish in the future.

Co-authorship network of co-authors of Gary P. Hingorani

This figure shows the co-authorship network connecting the top 25 collaborators of Gary P. Hingorani. A scholar is included among the top collaborators of Gary P. Hingorani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary P. Hingorani. Gary P. Hingorani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hinklin, Ronald J., Brian R. Baer, Steven A. Boyd, et al.. (2019). Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Bioorganic & Medicinal Chemistry. 28(1). 115232–115232. 10 indexed citations

Tunquist, Brian, Karin Brown, Gary P. Hingorani, et al.. (2012). Identification of Alpha 1-Acid Glycoprotein (AAG) As a Potential Patient Selection Biomarker for Improved Clinical Activity of the Novel KSP Inhibitor ARRY-520 in Relapsed and Refractory Multiple Myeloma (MM). Blood. 120(21). 1868–1868. 10 indexed citations

Otten, Jennifer, et al.. (2011). An In Vitro, High Throughput, Seven CYP Cocktail Inhibition Assay for the Evaluation of New Chemical Entities Using LC-MS/MS. Drug Metabolism Letters. 5(1). 17–24. 43 indexed citations

Rhodes, Susan P., Jennifer Otten, Gary P. Hingorani, Dylan P. Hartley, & Ronald B. Franklin. (2010). Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2. Journal of Pharmacological and Toxicological Methods. 63(3). 223–226. 26 indexed citations

Wallace, Eli M., Joseph P. Lyssikatos, James F. Blake, et al.. (2005). Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones. Journal of Medicinal Chemistry. 49(2). 441–444. 34 indexed citations

Reiter, Lawrence A., Kevin M. Koch, Anthony D. Piscopio, et al.. (1998). trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1781–1786. 11 indexed citations

Showell, Henry J., Maryrose J. Conklyn, Gary P. Hingorani, et al.. (1998). The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543. Journal of Pharmacology and Experimental Therapeutics. 285(3). 946–954. 37 indexed citations

Showell, Henry J., R Breslow, Maryrose J. Conklyn, Gary P. Hingorani, & Kevin M. Koch. (1996). Characterization of the pharmacological profile of the potent LTB₄antagonist CP‐105,696 on murine LTB₄receptorsin vitro.. British Journal of Pharmacology. 117(6). 1127–1132. 35 indexed citations

Prasad, J. V. N. Vara, Kimberly S. Para, Peter J. Tummino, et al.. (1995). Nonpeptidic Potent HIV-1 Protease Inhibitors: (4-Hydroxy-6-phenyl-2-oxo-2H-pyran-3-yl)thiomethanes That Span P1-P2' Subsites in a Unique Mode of Binding. Journal of Medicinal Chemistry. 38(6). 898–905. 27 indexed citations

10.

Showell, Henry J., E. R. Pettipher, Juan Cheng, et al.. (1995). The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 176–184. 53 indexed citations

11.

Wright, Clifford D., Wayne L. Cody, James B. Dunbar, et al.. (1994). Characterization of endothelins as chemoattractants for human neutrophils. Life Sciences. 55(21). 1633–1641. 32 indexed citations

12.

Cody, Wayne L., John X. He, Stephen T. Rapundalo, et al.. (1994). Structure-activity relationships in a series of monocyclic endothelin analogues. Bioorganic & Medicinal Chemistry Letters. 4(4). 567–572. 3 indexed citations

13.

Panek, Robert L., Terry C. Major, Gary P. Hingorani, et al.. (1992). Importance of secondary structure for endothelin binding and functional activity. Biochemical and Biophysical Research Communications. 183(2). 572–576. 8 indexed citations

14.

Panek, Robert L., Terry C. Major, Gary P. Hingorani, et al.. (1992). Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochemical and Biophysical Research Communications. 183(2). 566–571. 72 indexed citations

15.

Doherty, Annette M., Wayne L. Cody, Michelle Taylor, et al.. (1991). Structure-Activity Studies of the C-Terminal Region of the Endothelins and the Sarafotoxins. Journal of Cardiovascular Pharmacology. 17. S59–61. 23 indexed citations

16.

Otto, Claudia, et al.. (1991). Evaluation of quaternized and neutral muscarinic receptor ligands in normal and DES-treated rat. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 557–561. 2 indexed citations

17.

Cody, Wayne L., Annette M. Doherty, Stephen T. Rapundalo, et al.. (1991). Monocyclic Endothelins. Journal of Cardiovascular Pharmacology. 17. S62–64. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact